AI assistant
REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2012
Dec 18, 2012
29977_dirs_2012-12-18_b49011fe-6eca-4df2-a792-775f0664188d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REGENERON PHARMACEUTICALS INC (REGN)
CIK: 0000872589
Period of Report: 2012-12-14
Reporting Person: GOLDBERG MURRAY A (SVP Fin & Admin CFO Asst Secy)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-11-21 | Common Stock | G | 250.0 | $0.0 | Disposed | 83727.0 | Direct |
| 2012-12-03 | Common Stock | G | 14500.0 | $0.0 | Disposed | 69227.0 | Direct |
| 2012-12-14 | Common Stock | F | 4607.0 | $179.13 | Disposed | 64620.0 | Direct |
| 2012-12-17 | Common Stock | M | 1850.0 | $20.32 | Acquired | 66470.0 | Direct |
| 2012-12-03 | Common Stock | G | 14500.0 | $0.0 | Acquired | 14500.0 | Indirect |
| 2012-12-07 | Common Stock | G | 4250.0 | $0.0 | Disposed | 10250.0 | Indirect |
| 2012-12-10 | Common Stock | G | 6100.0 | $0.0 | Disposed | 4150.0 | Indirect |
| 2012-12-17 | Common Stock | G | 3400.0 | $0.0 | Disposed | 750.0 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-12-17 | Incentive Stock Option (right to buy) | $20.32 | M | 1850.0 | Disposed | 2016-12-18 | Common Stock (1850.0) | Direct |
| 2012-12-14 | Non-Qualified Stock Option (right to buy) | $21.25 | A | 56250.0 | Acquired | 2019-12-18 | Common Stock (56250.0) | Direct |
| 2012-12-14 | Non-Qualified Stock Option (right to buy) | $179.13 | A | 84500.0 | Acquired | 2022-12-14 | Common Stock (84500.0) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 5560.0 | Indirect |
Footnotes
F1: Gift of Common Stock to Charitable Foundation.
F2: Gift of Common Stock by reporting person to spouse.
F3: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F4: The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
F5: Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
F6: On December 18, 2009, the reporting person was granted an option to purchase 56,250 shares of Common Stock. The option vests, partially or in full, on December 31, 2012, based on the extent to which the company satisfies certain performance criteria during the period ending December 31, 2012. The performance criteria have been met and the option will vest as to all 56,250 shares on December 31, 2012.
F7: The stock option award vests in four equal annual installments, commencing one year after the date of grant.